Charles Schwab
VXRT

Charles Schwab’s Vaxart VXRT Stock Holding History

Charles Schwab’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-153,847
Closed -$69.5K – 3552
2025
Q2 		$69.5K Buy
153,847
+300
+0.2% +$131 ﹤0.01% 3431
2025
Q1 		$62.5K Hold
153,547
– – ﹤0.01% 3386
2024
Q4 		$102K Hold
153,547
– – ﹤0.01% 3396
2024
Q3 		$130K Sell
153,547
-40
-0% -$31 ﹤0.01% 3368
2024
Q2 		$102K Buy
153,587
+40
+0% +$33 ﹤0.01% 3473
2024
Q1 		$200K Hold
153,547
– – ﹤0.01% 3242
2023
Q4 		$88K Sell
153,547
-161,274
-51% -$111K ﹤0.01% 3357
2023
Q3 		$237K Sell
314,821
-424,822
-57% -$323K ﹤0.01% 3256
2023
Q2 		$540K Sell
739,643
-253,580
-26% -$236K ﹤0.01% 3013
2023
Q1 		$752K Buy
993,223
+18,038
+2% +$16.8K ﹤0.01% 2826
2022
Q4 		$937K Buy
975,185
+60,829
+7% +$86K ﹤0.01% 2789
2022
Q3 		$1.99M Buy
914,356
+30,087
+3% +$104K ﹤0.01% 2587
2022
Q2 		$3.1M Sell
884,269
-21,044
-2% -$78.6K ﹤0.01% 2399
2022
Q1 		$4.56M Buy
905,313
+18,900
+2% +$95.7K ﹤0.01% 2321
2021
Q4 		$5.56M Buy
886,413
+40,405
+5% +$276K ﹤0.01% 2301
2021
Q3 		$6.73M Buy
846,008
+8,691
+1% +$71.5K ﹤0.01% 2234
2021
Q2 		$6.27M Buy
837,317
+179,401
+27% +$1.25M ﹤0.01% 2237
2021
Q1 		$3.98M Buy
657,916
+52,990
+9% +$408K ﹤0.01% 2397
2020
Q4 		$3.46M Buy
604,926
+3,984
+0.7% +$25.3K ﹤0.01% 2395
2020
Q3 		$4M Buy
600,942
+480,760
+400% +$4.28M ﹤0.01% 2188
2020
Q2 		$1.06M Buy
+120,182
New +$345K ﹤0.01% 2607
2017
Q1 		– Sell
-2,365
Closed -$32K – 3069
2016
Q4 		$32K Hold
2,365
– – ﹤0.01% 3070
2016
Q3 		$50K Hold
2,365
– – ﹤0.01% 3026
2016
Q2 		$37K Hold
2,365
– – ﹤0.01% 3083
2016
Q1 		$40K Hold
2,365
– – ﹤0.01% 3034
2015
Q4 		$51K Hold
2,365
– – ﹤0.01% 3070
2015
Q3 		$52K Hold
2,365
– – ﹤0.01% 3067
2015
Q2 		$54K Hold
2,365
– – ﹤0.01% 3068
2015
Q1 		$60K Hold
2,365
– – ﹤0.01% 3056
2014
Q4 		$59K Hold
2,365
– – ﹤0.01% 3081
2014
Q3 		$65K Hold
2,365
– – ﹤0.01% 3052
2014
Q2 		$75K Hold
2,365
– – ﹤0.01% 3066
2014
Q1 		$159K Buy
+2,365
New +$146K ﹤0.01% 2997

Other funds holding VXRT

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HSA
HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
CFO
Custos Family Office Austin, Texas $167M AUM 21.03% 1-Year Est. Return
LCM
LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.91B AUM 24.25% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Charles Schwab's VXRT Position: Q3 2025 in Review

Charles Schwab sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 153,847 shares — an estimated $69.5K sold.

Charles Schwab first reported a position in VXRT in Q1 2014 and held it in 33 quarters. The position peaked at $6.73M in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Charles Schwab reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Charles Schwab sold 153,847 Vaxart shares in Q3 2025, an estimated $69.5K.
  • Charles Schwab first reported a position in Vaxart in Q1 2014 and held it in 33 quarters.
  • Charles Schwab's Vaxart position peaked at $6.73M in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.